Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 592, pseudogene (RNU6-592P)** is a classified pseudogene related to the U6 small nuclear RNA (snRNA) family[1][3][2]. Pseudogenes are DNA sequences similar to known genes but are typically nonfunctional; they may arise from retrotransposition or duplication events and typically lack regulatory elements required for expression or encode nonfunctional products[2][6]. U6 snRNA plays a central role as part of the spliceosome in pre-mRNA splicing, but pseudogenes like RNU6-592P have no established biological function and are presumed not to be expressed or to produce functional RNA[2][6]. There are no known roles for this pseudogene in disease, drug targeting, or use as a biomarker. **RNU6-592P is not a receptor, enzyme, or recognized therapeutic target**, and its inclusion as a “target” may reflect a misunderstanding or error in gene listing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 592, pseudogene (RNU6-592P).